Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
BJOG : an International Journal of Obstetrics and Gynaecology|July 28, 2005
Breastfeeding expectations versus reality: a cluster randomised controlled trialTina Lavender, Lisa Baker, Rebecca Smyth, et al.Brain Research|March 26, 2013
The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of miceLauriaselle Afanador, Ina Mexhitaj, Carolyn Diaz, et al.Drug and Alcohol Dependence|July 6, 2015
High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participantsJoshua A Barocas, Lisa Baker, Shawnika J Hull, et al.Molecular Neurobiology|August 19, 2024
Downregulation of Fidgetin-Like 2 Increases Microglial Function: The Relationship Between Microtubules, Morphology, and ActivityAustin N Smith, Alison Gregor, Lisa Baker, et al.BMC Palliative Care|January 30, 2016
'I don't think I'd be frightened if the statins went': a phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionalsAdam Todd, Holly Holmes, Sallie Pearson, et al.Clinical Immunology (Orlando, Fla.)|June 23, 2004
Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1Thomas M Luby, Geoffrey Cole, Lisa Baker, et al.Midwifery|March 3, 2009
Women's perceptions of being pregnant and having pregestational diabetesTina Lavender, Mary Jane Platt, Ediri Tsekiri, et al.Vaccine|October 15, 2010
In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunizationChristine M Barbon, Lisa Baker, Christa Lajoie, et al.Journal of Neuroinflammation|March 11, 2025
Fidgetin-like 2 knockdown increases acute neuroinflammation and improves recovery in a rat model of spinal cord injuryAustin N Smith, Samantha Nagrabski, Lisa Baker, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancersMichael G Kelly, Gil Mor, Alan Husband, et al.Pageof 5